当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Andrew Floyd
In the post-genomic era, it is essential for our comprehension of basic biology and disease pathogenesis to define functions for the entire protein family. This endeavor has recently benefited from a process we refer to as “systems biochemistry” that helps overcome traditional barriers to the characterization of poorly understood proteins by combining modern large-scale and classical reductionist approaches. Because mitochondria have a well-defined proteome, comprehensive analyses of the entire mitochondrial system have been possible, positioning understudied proteins for productive mechanistic investigations. The identification of new mitochondrial proteins associated with diseases and long-sought “missing” proteins that perform essential functions has sped up thanks to systems biochemistry methods of the past few years. Together, these studies are providing a molecular framework for the study of mitochondrial pathogenesis and advancing our comprehension of mitochondrial functions.